Supernus Pharmaceuticals
SUPN
#5037
Rank
HK$13.57 B
Marketcap
HK$233.08
Share price
1.78%
Change (1 day)
-34.47%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2026 (TTM): -HK$0.29 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.86 Billion. In 2025 the company made an earning of -HK$0.34 Billion a decrease over its 2024 earnings that were of HK$0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.29 Billion-14.29%
2025 -HK$0.34 Billion-152.66%
2024 HK$0.62 B1446.62%
2023 HK$40.65 M-92.36%
2022 HK$0.53 B-29.8%
2021 HK$0.75 B-49.79%
2020 HK$1.50 B12.99%
2019 HK$1.33 B7.58%
2018 HK$1.24 B54.9%
2017 HK$0.80 B84.25%
2016 HK$0.43 B202.27%
2015 HK$0.14 B-462.04%
2014 -HK$39.75 Million-94%
2013 -HK$0.67 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$146.82 B-51,828.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$56.60 B-20,044.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$272.68 B-96,171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$88.87 B-31,411.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-HK$1.67 Billion 485.87%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$11.91 B-4,299.11%๐Ÿ‡บ๐Ÿ‡ธ USA